These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19335122)

  • 1. Evaluation of Ferucarbotran (Resovist) as a photoacoustic contrast agent / Evaluation von Ferucarbotran (Resovist) als photoakustisches Kontrastmittel.
    Mienkina MP; Friedrich CS; Hensel K; Gerhardt NC; Hofmann MR; Schmitz G
    Biomed Tech (Berl); 2009 Apr; 54(2):83-8. PubMed ID: 19335122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of small (Tonan T; Fujimoto K; Azuma S; Ono N; Matsushita S; Kojiro M; Hayabuchi N
    Eur J Radiol; 2007 Oct; 64(1):133-9. PubMed ID: 17408900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of hepatic metastasis: manganese- and ferucarbotran-enhanced MR imaging.
    Choi JY; Kim MJ; Kim JH; Kim SH; Ko HK; Lim JS; Oh YT; Chung JJ; Yoo HS; Lee JT; Kim KW
    Eur J Radiol; 2006 Oct; 60(1):84-90. PubMed ID: 16920315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of objects in photoacoustic tomography using selective filtering.
    Shin DH; Yang Y; Song CG
    Biomed Mater Eng; 2015; 26 Suppl 1():S1223-30. PubMed ID: 26405881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Labeling of mesenchymal stem cells with different superparamagnetic particles of iron oxide and detectability with MRI at 3T].
    Ittrich H; Lange C; Dahnke H; Zander AR; Adam G; Nolte-Ernsting C
    Rofo; 2005 Aug; 177(8):1151-63. PubMed ID: 16021549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [MR contrast agent: resovist (SH U 555A)].
    Nakajima H; Ichikawa T
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():328-32. PubMed ID: 11761967
    [No Abstract]   [Full Text] [Related]  

  • 7. Detection of small hepatocellular carcinoma: comparison of conventional gadolinium-enhanced MRI with gadolinium-enhanced MRI after the administration of ferucarbotran.
    Kim YK; Kim CS; Han YM
    Br J Radiol; 2009 Jun; 82(978):468-84. PubMed ID: 19124563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superparamagnetic iron oxide (SPIO)-enhanced liver MRI with ferucarbotran: efficacy for characterization of focal liver lesions.
    Namkung S; Zech CJ; Helmberger T; Reiser MF; Schoenberg SO
    J Magn Reson Imaging; 2007 Apr; 25(4):755-65. PubMed ID: 17335040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging of liver metastases: experimental comparison of anionic and conventional superparamagnetic iron oxide particles with a hepatobiliary contrast medium during dynamic and uptake phases.
    Kaufels N; Korn R; Wagner S; Schink T; Hamm B; Taupitz M; Schnorr J
    Invest Radiol; 2008 Jul; 43(7):496-503. PubMed ID: 18580332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging-guided balloon angioplasty of coarctation of the aorta: a pilot study.
    Krueger JJ; Ewert P; Yilmaz S; Gelernter D; Peters B; Pietzner K; Bornstedt A; Schnackenburg B; Abdul-Khaliq H; Fleck E; Nagel E; Berger F; Kuehne T
    Circulation; 2006 Feb; 113(8):1093-100. PubMed ID: 16490822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic characterization of focal hepatic lesions: role of ferucarbotran-enhanced dynamic MR imaging using T2-weighted multishot spin-echo echo-planar sequence.
    Hori M; Murakami T; Kim T; Iannaccone R; Abe H; Onishi H; Tomoda K; Catalano C; Passariello R; Nakamura H
    J Magn Reson Imaging; 2006 Apr; 23(4):509-19. PubMed ID: 16523480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conspicuity of zones of ablation after radiofrequency ablation in porcine livers: comparison of an extracellular and an SPIO contrast agent.
    Bangard C; Stippel DL; Berg F; Kasper HU; Hellmich M; Fischer JH; Hölscher A; Lackner K; Gossmann A
    J Magn Reson Imaging; 2008 Jul; 28(1):263-70. PubMed ID: 18581392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of magnetic nanoparticle samples made from biocompatible ferucarbotran by time-correlation magnetic particle imaging reconstruction method.
    Ishihara Y; Honma T; Nohara S; Ito Y
    BMC Med Imaging; 2013 Jun; 13():15. PubMed ID: 23734917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [T1-weighted dynamic MRI with new superparamagnetic iron oxide particles (Resovist): results of a phantom study as well as 25 patients].
    Müller M; Reimer P; Wiedermann D; Allkemper T; Marx C; Tombach B; Rummeny EJ; Shamsi K; Balzer T; Peters PE
    Rofo; 1998 Mar; 168(3):228-36. PubMed ID: 9551108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photoacoustic imaging of the bladder: a pilot study.
    Kamaya A; Vaithilingam S; Chung BI; Oralkan O; Khuri-Yakub BT
    J Ultrasound Med; 2013 Jul; 32(7):1245-50. PubMed ID: 23804347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ferucarbotran-enhanced 3.0-T magnetic resonance imaging using parallel imaging technique compared with triple-phase multidetector row computed tomography for the preoperative detection of hepatocellular carcinoma.
    Kim SJ; Kim SH; Lee J; Chang S; Kim YS; Kim SH; Jeon YH; Choi D
    J Comput Assist Tomogr; 2008; 32(3):379-85. PubMed ID: 18520541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ferucarbotran-enhanced magnetic resonance imaging versus gadoxetic acid-enhanced magnetic resonance imaging for the preoperative detection of hepatocellular carcinoma: initial experience.
    Lee JY; Kim SH; Jeon YH; Lee J; Kim MJ; Choi D; Lee WJ
    J Comput Assist Tomogr; 2010 Jan; 34(1):127-34. PubMed ID: 20118735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-liver contrast and subjective tumor conspicuity of respiratory-triggered T2-weighted fast spin-echo sequence compared with T2*-weighted gradient recalled-echo sequence for ferucarbotran-enhanced magnetic resonance imaging of hepatic malignant tumors.
    Ishiyama K; Hashimoto M; Izumi J; Watarai J; Shibata S; Sato T; Yamamoto Y
    J Magn Reson Imaging; 2008 Jun; 27(6):1322-6. PubMed ID: 18504744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [MRI of arthritis with the USPIO SH U 555 C: optimization of T1 enhancement].
    Simon G; Daldrup-Link H; von Vopelius-Feldt J; Wendland M; Fu Y; Schlegel J; Rummeny E
    Rofo; 2006 Feb; 178(2):200-6. PubMed ID: 16435251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of ferucarbotran in MR imaging of the liver: a pre- and postexamination questionnaire-based multicenter investigation.
    Onishi H; Murakami T; Kim T; Hori M; Hirohashi S; Matsuki M; Narumi Y; Imai Y; Sakurai K; Nakamura H
    J Magn Reson Imaging; 2009 Jan; 29(1):106-11. PubMed ID: 19097079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.